Literature DB >> 16171575

Interactions between canine plasminogen and 8-anilino-1-naphthalene sulfonate: structural insights from a fluorescent probe.

D M Carter1, J A Kornblatt.   

Abstract

Canine plasminogen (DPgn) binds the fluorescent molecule, 8-anilino-1-naphthalene sulfonate (ANS). Binding is favored by low pH as shown by steady-state fluorescence, native PAGE and isothermal titration calorimetry. Binding occurs at multiple sites. A strong site binds ANS with a Ka of 3.3 x 10(4) M(-1). Two weaker sites were observed with association constants of 6.2 x 10(3) M(-1) and 360 M(-1), respectively. ANS binds equally well to both the closed and opened conformations of DPgn at pH 3.0. At low pH there are changes in protein tertiary structure as monitored by sedimentation velocity analysis and circular dichroism. Binding sites for ANS were located in the proteolytic domain as well as the kringle domains. However, it is unlikely that binding occurs within the lysine binding sites of each respective kringle. Taken together, the data suggest that ANS may be binding to a pH induced molten globule state of DPgn.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16171575

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  3 in total

1.  Reduction of canine plasminogen leads to an expanded molecule which precipitates.

Authors:  Jack A Kornblatt
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

2.  Canine plasminogen: spectral responses to changes in 6-aminohexanoate and temperature.

Authors:  Jack A Kornblatt; Tanya A Barretto; Ketevan Chigogidze; Bahati Chirwa
Journal:  Anal Chem Insights       Date:  2007-03-22

3.  Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist.

Authors:  Ramil F Latypov; Dingjiang Liu; Kannan Gunasekaran; Timothy S Harvey; Vladimir I Razinkov; Andrei A Raibekas
Journal:  Protein Sci       Date:  2008-02-27       Impact factor: 6.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.